Nasal septum perforation: a side effect of bevacizumab chemotherapy in breast cancer patients

Abstract

A high incidence of nasal septum perforation has been shown in pts with breast cancer receiving bevacizumab together with chemotherapy. Several mechanisms could be involved (mucositis, delayed tissue repair, antiangiogenic action of taxanes).